Yiyao Technology Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2018

Location

Beijing China

Primary Industry

Pharmaceuticals

About

Established in 2018 and based in Beijing, China, Yiyao Technology operates as a Technology is a pharmaceutical company that focuses on developing medicine via utilizing artificial intelligence technology. As of 2022, the company raised financial from Powercloud, and Innovation Angel Funds. The company's AI systems can be categorized into Deep Learning based Efficacy Prediction System (DLEPS), Ligand Ensembles based Small Molecules’ Design, Intelligent Docking System driven by Reinforcement Learning, and Retrosynthesis Prediction System for Natural Products. DLEPS can be used to find novel targets for diseases by finding the compound first, then studying their MOA. The overall accuracy of DLEPS at the animal level is around 60%.

Current Investors

Powercloud, Innoangel Fund, Sangel Capital

Request a demo to show more

Primary Industry

Pharmaceuticals

Sub Industries

Biopharmaceuticals, Pharmaceutical Research & Development

Website

www.gigaceuticals.com

Verticals

Artificial Intelligence

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.